Paul M Tulkens (P Tulkens)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 17

Top Topics

Biofilm Formation

Pseudomonas Aeruginosa

Staphylococcus Aureus

Top Venues

Antimicrobial agents and chemotherapy

Antibiotics (Basel, Switzerland)

The Journal of antimicrobial chemotherapy

Nature communications

Université catholique de Louvain

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université catholique de Louvain

Belgium

Professeur ordinnaire (Full Professor) :: Ecole de Pharmacie (School of Pharmacy)

Université de Mons

Belgium

Chargé de cours (Lecturer) :: Biochimie humaine et biochimie pathologique

Université catholique de Louvain

Belgium

Professeur (Professor) :: Ecole de Pharmacie (School of Pharmacy)

Université Catholique de Louvain

Belgium

Chargé de cours (Lecturer) :: Ecole de Pharmacie (School of Pharmacy)

Fonds National de la Recherche Scientifique

Belgium

Maître de recherches (Senior Research Associate) :: Université catholique de Louvain - International Institute of Cellular and Moelcular pathology

Fonds National de la Recherche Scientifique

Belgium

Chercheur qualifié (Research Associate) :: Université catholique de Louvain - International Institute of Cellular and Molecular Pathology

International Institute of Cellular and Molecular Pathology

Belgium

Research fellow :: Biochemistry Unit

Fonds National de la Recherche Scientifique

Belgium

Chargé de recherches (Post-Doctoral fellow) :: Université catholique de Louvain - Laboratoire de Chimie Physiologique)

Fonds National de la Recherche Scientifique

Belgium

Aspirant (Research Fellow) :: Université catholique de Louvain - Laboratoire de Chimie Physiologique

Fonds National de la Recherche Scientifique

Belgium

Stagiaire de recherches (Research Trainee) :: Université catholique de Louvain - Laboratoire de Chimie Physiologique

Publications

Tamara V Milosevic, Gaëlle Vertenoeil, William Vainchenker, Paul M Tulkens, Stefan N Constantinescu, Françoise Van Bambeke
Oxazolidinone antibiotics impair ex vivo megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets. Antimicrobial agents and chemotherapy (2024)
Françoise Van Bambeke, Sebastian Wicha, Paul M Tulkens, Markus Zeitlinger
Editorial for the Special Issue "A Themed Issue in Honor of Professor Hartmut Derendorf-Outstanding Contributions in the Fields of Quantitative Clinical Pharmacology". Antibiotics (Basel, Switzerland) 12 (2) (2023)
Françoise Van Bambeke, Sebastian Wicha, Paul M Tulkens, Markus Zeitlinger
Editorial for the Special Issue "A Themed Issue in Honor of Professor Hartmut Derendorf-Outstanding Contributions in the Fields of Quantitative Clinical Pharmacology". Antibiotics (Basel, Switzerland) 12 (2) (2023)
Françoise Van Bambeke, Sebastian Wicha, Paul M Tulkens, Markus Zeitlinger
Editorial for the Special Issue "A Themed Issue in Honor of Professor Hartmut Derendorf-Outstanding Contributions in the Fields of Quantitative Clinical Pharmacology". Antibiotics (Basel, Switzerland) 12 (2) (2023)
Frédéric Peyrusson, Tiep K Nguyen, Julien M Buyck, Sandrine Lemaire, Gang Wang, Cristina Seral, Paul M Tulkens, Françoise Van Bambeke
In Vitro Models for the Study of the Intracellular Activity of Antibiotics. Methods in molecular biology (Clifton, N.J.) 2357 (2022)
Perrin Ngougni Pokem, Peter Matzneller, Steven Vervaeke, Xavier Wittebole, Lieven Goeman, Marie Coessens, Eleonora Cottone, Arnaud Capron, Beatrix Wulkersdorfer, Pierre Wallemacq, Johan W Mouton, Anouk E Muller, Markus Zeitlinger, Pierre François Laterre, Paul M Tulkens, Françoise Van Bambeke
Binding of temocillin to plasma proteins in vitro and in vivo: the importance of plasma protein levels in different populations and of co-medications. The Journal of antimicrobial chemotherapy 77 (10) (2022)
Perrin Ngougni Pokem, Xavier Wittebole, Christine Collienne, Hector Rodriguez-Villalobos, Paul M Tulkens, Laure Elens, Françoise Van Bambeke, Pierre-François Laterre
Population Pharmacokinetics of Temocillin Administered by Continuous Infusion in Patients with Septic Shock Associated with Intra-Abdominal Infection and Ascitic Fluid Effusion. Antibiotics (Basel, Switzerland) 11 (7) (2022)
Hélène Thirot, Caroline Briquet, Frédéric Frippiat, Frédérique Jacobs, Xavier Holemans, Séverine Henrard, Paul M Tulkens, Anne Spinewine, Françoise Van Bambeke
Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers. Antibiotics (Basel, Switzerland) 10 (5) (2021)
Christian Eckmann, Paul M Tulkens
Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics. The Journal of antimicrobial chemotherapy 76 (Suppl 4) (2021)
A Somers, A Spinewine, Isabel Spriet, S Steurbaut, Paul M Tulkens, Jean-Daniel Hecq, L Willems, H Robays, M Dhoore, H Yaras, I Vanden Bremt, M Haelterman
Development of clinical pharmacy in Belgian hospitals through pilot projects funded by the government. Acta clinica Belgica 74 (2) (2018)
Wafi Siala, Hector Rodriguez-Villalobos, Prabhavathi Fernandes, Paul M Tulkens, Françoise Van Bambeke
Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in In Vitro Static and Dynamic Models. Antimicrobial agents and chemotherapy 62 (7) (2018)
Frédéric Peyrusson, Paul M Tulkens, Françoise Van Bambeke
Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells. Antimicrobial agents and chemotherapy 62 (4) (2018)
Tamara V Milosevic, Valéry L Payen, Pierre Sonveaux, Giulio G Muccioli, Paul M Tulkens, Françoise Van Bambeke
Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 Monocytes. Antimicrobial agents and chemotherapy 62 (3) (2018)
Ahalieyah Anantharajah, Julien M Buyck, Charlotta Sundin, Paul M Tulkens, Marie-Paule Mingeot-Leclercq, Françoise Van Bambeke
Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms. Antimicrobial agents and chemotherapy 61 (6) (2017)
Isabelle K Delattre, Fabio S Taccone, Frédérique Jacobs, Maya Hites, Thierry Dugernier, Herbert Spapen, Pierre-François Laterre, Pierre E Wallemacq, Françoise Van Bambeke, Paul M Tulkens
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective? Expert review of anti-infective therapy 15 (7) (2017)
Muhammad-Hariri Mustafa, Hussein Chalhoub, Olivier Denis, Ariane Deplano, Anne Vergison, Hector Rodriguez-Villalobos, Michael M Tunney, J Stuart Elborn, Barbara C Kahl, Hamidou Traore, Francis Vanderbist, Paul M Tulkens, Françoise Van Bambeke
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe. Antimicrobial agents and chemotherapy 60 (11) (2016)
Wafi Siala, Soňa Kucharíková, Annabel Braem, Jef Vleugels, Paul M Tulkens, Marie-Paule Mingeot-Leclercq, Patrick Van Dijck, Françoise Van Bambeke
The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase. Nature communications 7 (2016)
Frédéric Peyrusson, Deborah Butler, Paul M Tulkens, Françoise Van Bambeke
Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages. Antimicrobial agents and chemotherapy 59 (9) (2015)
Julien M Buyck, Frédéric Peyrusson, Paul M Tulkens, Françoise Van Bambeke
RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria. Antimicrobial agents and chemotherapy 59 (8) (2015)
Shawn Flanagan, Edward E McKee, Debaditya Das, Paul M Tulkens, Hiromi Hosako, Jill Fiedler-Kelly, Julie Passarell, Ann Radovsky, Philippe Prokocimer
Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function. Antimicrobial agents and chemotherapy 59 (1) (2014)
Julien M Buyck, Paul M Tulkens, Françoise Van Bambeke
Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes. Antimicrobial agents and chemotherapy 59 (1) (2014)